1. Background {#sec0005}
=============

Extended release potassium salts are indicated in induced or acquired hypokalemic conditions. The potassium overdose could generate hyperkalemic states, especially if the patient has impaired renal function or if there has been a large ingestion of salts (toxic dosage: 2 mEq/kg) [@bib0005]. When a patient presents a large ingestion of extended release potassium tablets, clinical manifestations could be delayed even more than 24 h and concretions could be formed in the stomach. Concretions complicates the decontamination by gastric lavage, so that after this procedure in these patients, it is possible to find tablets remaining in the stomach, even in 88.2% of cases [@bib0010].

The great absorption that follows to a massive ingestion of potassium salts causes myocardial conduction disturbances and metabolic acidosis.

The correct technique for gastrointestinal decontamination in cases of massive overdose of extended-release tablets is not well established, nowadays, toxicologists continue to consider use of whole bowel irrigation (WBI), endoscopy or even surgery to evacuate tablet remaining from the stomach [@bib0005].

2. Case report {#sec0010}
==============

A 42 year old woman with history of borderline personality disorder and a suicide attempt with potassium salts (50 tablets) one year earlier presented to the emergency room after intake of 100 tablets of extended release potassium chloride (1000 mEq), 50 mg of liquid clonazepam, and an undisclosed amount of ethanol at home.

She recognized this as a new suicide attempt and presented with somnolence, tachycardia and exhalation of ethanol odor 2 h after ingestion. Her vital signs were: blood pressure 130/90 mm Hg, pulse was 97 beats/min, respirations were 22 breaths/min, temperature was 36.5 °C, and oxygen saturation was 98% on room air.

A 12 lead electrocardiogram demonstrated sinus tachycardia with normal QRS duration and unaltered T-waves. Potassium level was 3.9 mmol/L, blood gas analysis revealed pH 7.25, HCO3 17.5 mEq/L and lactate 4.9 mmol/L. A standard toxicological screen was negative for all agents. Ethanol level was 90.80 mg/dl. Finally a plain film of the abdomen showed multiple opacities in the region of the stomach ([Fig. 1](#fig0005){ref-type="fig"}). Other agents, including acetaminophen and salicylates were reported to be absent.Fig. 1Abdominal radiography with multiple radioopacities in the stomach (red arrow).

A venous access was placed. After that, a gastric lavage with a 20-french orogastric tube (maximum size in our hospital) was performed. However, no tablets were recovered during this procedure. Also, a single dose of activated charcoal was performed in order to treat a possible coingestant. Anti-hyperkalemic measures were not necessary at that time. However, a transcutaneous pacemaker was placed.

Given her background and the gastric lavage that was ineffective, an abdominal radiography was performed in order to identify the location of the tablets. The radiography showed multiple radiopacities in the stomach and the possibility of a pharmacobezoar was considered. Consultation with the gastroenterology service was done to request an endoscopy for removal of the suspected pharmacobezoar. A total of 99 of the 100 tablets that were either isolated or forming concretions were removed with an endoscopic basket ([Fig. 2](#fig0010){ref-type="fig"}, [Fig. 3](#fig0015){ref-type="fig"}).Fig. 2Endoscopic removal of the tablets.Fig. 3Removed tablets.

After gastric decontamination, clinical outcome was satisfactory, pharmacological correction of acidosis was not needed and she did not develop hyperkalemia or cardiovascular impairments. The patient was intubated for the procedure and extubated 18 h later. After that, she was discharged to the psychiatry service 48 h later.

3. Discussion {#sec0015}
=============

The potassium excess could be absorbed by the intracellular compartment to maintain serum levels under 5.5 mEq/L, but unfortunately this mechanism is saturable [@bib0015]. In this context, potassium serum levels over 6.0 mEq/L should be considered risky and need to be treated immediately [@bib0020], [@bib0025]. Although there is no clear relationship between the serum level and heart rhythm disturbances, we know that the risk of dysrhythmias is increased if rapid absorption of potassium occurs [@bib0005], [@bib0020], [@bib0030], [@bib0035].

Many drugs are capable to form concretions as in the case of amitriptyline, salicylates, carbamazepine, iron, potassium salts and other extended release preparations, with or without an enteric coat [@bib0040], [@bib0045], [@bib0050], [@bib0055].

The gastric decontamination is an essential procedure in the treatment of patients with an oral drug overdose; however, the appropriate technique to remove a bezoar is still controversial.

The gastric lavage and activated charcoal administration have both been demonstrated to be poorly effective on patients with pharmacobezoars. Moreover, in Mexico there are no orogastric tubes with a recommended diameter to remove extended release tablets (36--40 Fr).

Nowadays, the available techniques to remove pharmacobezoars include: WBI (only small size bezoars), endoscopy and surgical extraction. In this context, the main factors to consider before selecting a decontamination technique are: drug toxicity, pharmacobezoar size and location, clinical condition of the patient and availability of the resources (polyethylene glycol, operating room, etc.) [@bib0050].

Despite the fact that WBI has been demonstrated in some reports be safe and to improve the clinical condition of these patients, at this time there is no strong evidence of its efficacy. It requires several hours to clarify the effluent, also, it is necessary to have a normal bowel function and it could not be effective if a big bezoar exists in the stomach. In the case of perforation, intestinal occlusion, active bleeding, hemodynamic instability or vomiting, the WBI are contraindicated [@bib0060]. Also, in the case of a potassium salts overdose, one of the most important causes of morbidity is the cardiac rhythm disturbance with hemodynamic instability, which limits the use of WBI.

We considered the high risk of massive absorption with hemodynamic implications and started management with airway protection, placement of a pacemaker and decontamination by endoscopy [@bib0065]. Furthermore, our patient had a history of a previous suicide attempt with 50 tablets of extended release potassium salts. She developed hyperkalemia, metabolic acidosis and hyperacute T waves, and was hospitalized seven days in an intensive care unit. In the second attempt, even though the patient increased the ingestion to 100 tablets of the same drug, she did not develop any complication and was discharged two days after ingestion. We strongly concur that if a pharmacobezoar is suspected endoscopy should be considered in order to avoid a massive absorption [@bib0050], [@bib0070], [@bib0105].

On the other hand, the multiple introductions of the endoscope could increase the risk of airway injuries and aspiration of gastric content [@bib0075]. Despite that, in our case, the equipment was introduced eighteen times and no complications were presented. For this reason, we consider the endoscopic removal of bezoars a therapeutical option for uncomplicated patients and should be performed early if the medical center is short of appropriate orogastric tubes [@bib0005], [@bib0080].

Gunja [@bib0085] describes a case of a patient who ingested 100 tablets of extended release potassium chloride with severe hyperkalemia 5 h after the ingestion [@bib0085]. Also, Saxena [@bib0090] describes a case of a woman who ingested 16 mEq/Kg of potassium salts and developed severe hyperkalemia with cardiac arrest in the first hour after the ingestion. Finally, Colledge [@bib0095] reported another case with an intake of approximately 100 tablets with hyperkalemia and ventricular tachycardia demonstrating the effects of a rapid absorption in massive ingestions of potassium salts. In our case, due to the early endoscopic removal of tablets, the patient did not increase potassium serum levels and complications were not registered.

4. Conclusions {#sec0020}
==============

This was a case of intentional potassium, ethanol and clonazepam overdose resulting in mild metabolic acidosis, hyperlactatemia and sinus tachycardia at 2 h after ingestion, without hyperkalemia and after utilizing endoscopy in order to remove 100 isolated tablets and forming pharmacobezoars. In this case, the bezoar formation could lead to massive absorption of potassium and increase the risk of hyperkalemic disturbances. In addition to standard treatments for hyperkalemia, this case report demonstrates the benefit from endoscopy in extended-release potassium bezoar formation, considering the hospital resources, time from the ingestion and clinical status of the patient. Also, this study asks whether endoscopy should be used as an initial measure of decontamination in patients who have ingested a large quantity of tablets, particularly in centers where there is a lack of adequate tubes for gastric lavage ([Table 1](#tbl0005){ref-type="table"}).Table 1Case development.TimeSerumpotassium, blood gasTherapeuticsArrivalK 3.9 mmol/LParenteral solutionspH 7.25, HCO~3~ 17, Lact 4.9 mmol/LNot Anti hyperkalemic measures. TranscutaneouspacemakerEndoscopy  5 h\
(after endoscopy)K 3.5 mmol/LNot Anti hyperkalemicmeasurespH 7.39, HCO~3~ 18.3, Lact 0.6 mmol/L  8 hK 3.4 mmol/LNot Anti hyperkalemicmeasures  18 hK 4.3 mmol/LNot Anti hyperkalemic measures. Transcutaneous pacemaker was removed

We concur that in selected cases endoscopy could be used instead of gastric lavage as first decontamination measure, although, a clinical guideline for the use of endoscopy as a decontamination method still need to be created.

Cases of extended release potassium salts reported are summarized below ([Table 2](#tbl0010){ref-type="table"}).Table 2Reported cases.ReportPatientTime (intake)Extended release KClFindingsSerum KTherapyCharles et al. (1978)32, F18 h47 tabs (8 mmol)Diarrhea, death10.8 mmol/l\
(intraocular)0Illingworth (1980) [@bib0110]36, M5 hUnknown\
Tabs, 8 mmolWide complex tachycardia (125×)8.9 mml/l5, 6, 7, 9, 10Colledge et al. (1988)24, F2 h100 tabsHyperacute T waves, sinus tachycardia 110×. Ventricular tachycardia\
6.4 mmol/l1, 5, 6, 7Steedman (1988) [@bib0125]\
27, F12 h60 tabs (8 mmol)1st degree AV blockade, QRS widening and hyperacute T waves9.1 mmol/l5, 6, 7, 9,12Peeters et al. (1998)62, F?300 tabs (2.4 mmol)Abdominal distension. One month later gastric necrosisNot report358, M5 h20 tabs of extended release KCl (630 mg). Bendoflurazide and phenylbutazoneLeft ventricular heart failure8 mmol/l1, 6, 9, 1026, M3.5 h10 tabsdextropropoxyphene -- acetaminophen\
40 tabs of extended release KCl (8 mmol)Unaltered EKG. Nausea and vomiting, Asystole, death in gastric lavage9.3 mmol/l12 months\
M24 h5 tabs (8 mmol)Death10.1 mmol/l0Whitaker et al. (2000) [@bib0130]30 months\
M\
30 min32 tabsTachycardia (155×) 1st degree AV blockade. Hyperacute T waves9.2 mmol/l2, 5, 6, 9, 10Su (2001) [@bib0135]50, F1 h100 tabs (10 mEq)\
Alprazolam and ibuprofenHyperacute T waves8.2 mmol/l1, 2, 4, 5, 6, 7, 9, 1317 a, M10 h20--30 tabs (10 mEq)Tachycardia, nausea, vomiting and diarrhea5.5 mmol/l2Wan (2007) [@bib0120]86, MChronic70 tabs (8 mmol)Asthenia and adinamia6.8 mmol/l2, 5, 6, 7Gunja (2011)42, F90 min40 tabs (8 mmol)Tachycardia (100×)5.5 mmol/l6, 242, F5 h100 tab (8 mmol)Tachycardia (124×)8.5 mmol/l5, 6, 7, 46, M2 h10--20 tab (8 mmol)Plane T waves7.6 mmol/l4, 5, 6, 7, 8.Saxena (1988)46, F1 h100 tab (8 mmol)Cardiac arrest9.6 mmol/l1, 5, 6, 7, 9, 11, 14.Briggs Albert et al. (2013) [@bib0140]44, F75 min30 tab (20 mEq)Mildly peaked T waves7.3 mmol/L2, 3, 5, 6, 7, 8.Pérez et al. (2013)42, F2 h100 tab (10 mEq)Metabolic acidosis, hyperlactatemia and sinus tachycardia with normal T waves3.9 mmol/L1, 3, 11[^5]
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[^1]: Mobile: +52 1 55 48706380.

[^2]: Mobile: +52 1 722 5189242.

[^3]: Mobile: +52 1 55 39896337.

[^4]: Mobile: +52 1 55 45832697.

[^5]: 1: gastric lavage; 2: whole bowel irrigation; 3: endoscopy; 4: hemodialysis; 5: calcium; 6: insulin/glucose; 7: sodium bicarbonate; 8: β-2 agonist; 9: ion exchange resin; 10: furosemide; 11: activated charcoal; 12: mannitol; 13: cardiac pacemaker and 14: advanced cardiac resuscitation.
